Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

"Akinetic depression" in schizophrenia.

Van Putten T, May RP.

Arch Gen Psychiatry. 1978 Sep;35(9):1101-7.

PMID:
28711
2.

Using antipsychotic agents in older patients.

Alexopoulos GS, Streim J, Carpenter D, Docherty JP; Expert Consensus Panel for Using Antipsychotic Drugs in Older Patients.

J Clin Psychiatry. 2004;65 Suppl 2:5-99; discussion 100-102; quiz 103-4. Review.

3.

[Use of antidepressant drugs in schizophrenic patients with depression].

Micallef J, Fakra E, Blin O.

Encephale. 2006 Mar-Apr;32(2 Pt 1):263-9. Review. French.

PMID:
16910628
4.

The effects of clozapine on negative symptoms in patients with schizophrenia with minimal positive symptoms.

Brar JS, Chengappa KN, Parepally H, Sandman AR, Kreinbrook SB, Sheth SA, Ganguli R.

Ann Clin Psychiatry. 1997 Dec;9(4):227-34. Review.

PMID:
9511946
5.

New drugs for schizophrenia: an update for family physicians.

Amadio PB, Cross LB, Amadio P Jr.

Am Fam Physician. 1997 Sep 15;56(4):1149-56, 1159-60. Review. Erratum in: Am Fam Physician 1998 Jan 1;57(1):40.

PMID:
9310066
6.

[Schizophrenia, diabetes mellitus and antipsychotics].

Gury C.

Encephale. 2004 Jul-Aug;30(4):382-91. Review. French.

PMID:
15538314
7.

[Incidence of the deficit form in refractory schizophrenia].

Samuelian JC.

Encephale. 1996 Jun;22 Spec No 2:19-23. Review. French.

PMID:
8767037
8.

[Treatment of negative symptoms in schizophrenia by amisulpride. Review of the literature].

Pélissolo A, Krebs MO, Olié JP.

Encephale. 1996 May-Jun;22(3):215-9. Review. French.

PMID:
8767050
9.

[Antidepressant treatment of schizophrenic patients].

Caroli F, Baldacci-Epinette C, Ribeyre P.

Encephale. 1993 Jul;19 Spec No 2:393-6. Review. French.

PMID:
7904237
10.

[Efficacy of atypical antipsychotics in depressive syndromes].

Quintin P, Thomas P.

Encephale. 2004 Nov-Dec;30(6):583-9. Review. French.

PMID:
15738862
11.

Clozapine withdrawal-emergent dystonias and dyskinesias: a case series.

Ahmed S, Chengappa KN, Naidu VR, Baker RW, Parepally H, Schooler NR.

J Clin Psychiatry. 1998 Sep;59(9):472-7. Review.

PMID:
9771818
12.

Good tolerability equals good results: the patient's perspective.

Naber D, Karow A.

Eur Neuropsychopharmacol. 2001 Oct;11 Suppl 4:S391-6. Review.

PMID:
11587886
13.

Ziprasidone: an atypical antipsychotic drug for the treatment of schizophrenia.

Stimmel GL, Gutierrez MA, Lee V.

Clin Ther. 2002 Jan;24(1):21-37. Review.

PMID:
11833834
14.

Improvement of negative symptoms: Concepts, definition and assessment.

Andreasen NC.

Int Clin Psychopharmacol. 1997 May;12 Suppl 2:S7-10. Review.

PMID:
9218162
15.

Behavioral toxicity of antipsychotic drugs.

Van Putten T, Marder SR.

J Clin Psychiatry. 1987 Sep;48 Suppl:13-9. Review.

PMID:
2887552
16.

[Benzodiazepines and schizophrenia, a review of the literature].

Gaillard R, Ouanas A, Spadone C, Llorca PM, Lôo H, Baylé FJ.

Encephale. 2006 Nov-Dec;32(6 Pt 1):1003-10. Review. French.

PMID:
17372546
18.

[Depression and schizophrenia].

Smulevich AV.

Zh Nevrol Psikhiatr Im S S Korsakova. 2003;103(4):4-13. Review. Russian.

PMID:
12800545
19.

Long-term treatment of mood disorders in schizophrenia.

Azorin JM.

Acta Psychiatr Scand Suppl. 1995;388:20-3. Review.

PMID:
7541599
20.

Sleep in schizophrenia patients and the effects of antipsychotic drugs.

Monti JM, Monti D.

Sleep Med Rev. 2004 Apr;8(2):133-48. Review.

PMID:
15033152

Supplemental Content

Support Center